Role of BDNF/TrkB pathway in the visual system: therapeutic implications for glaucoma

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Introduction: Neuroprotective therapeutics are needed to treat glaucoma, an optic neuropathy that results in death of retinal ganglion cells (RGCs). Areas covered: The BDNF/TrkB pathway is important for RGC survival. Temporal and spatial alterations in the BDNF/TrkB pathway occur in development and in response to acute optic nerve injury and to glaucoma. In animal models, BDNF supplementation is successful at slowing RGC death after acute optic nerve injury and in glaucoma, however, the BDNF/TrkB signaling is not the only pathway supporting long term RGC survival. Expert commentary: Much remains to be discovered about the interaction between retrograde, anterograde, and retinal BDNF/TrkB signaling pathways in both neurons and glia. An ideal therapeutic agent for glaucoma likely has several modes of action that target multiple mechanisms of neurodegeneration including the BDNF/TrkB pathway.

Original languageEnglish (US)
Pages (from-to)69-81
Number of pages13
JournalExpert Review of Ophthalmology
Volume12
Issue number1
DOIs
StatePublished - Jan 2 2017

Fingerprint

Visual Pathways
Brain-Derived Neurotrophic Factor
Glaucoma
Optics
Retinal Ganglion Cells
Optic Nerve Injuries
Cell death
Neurons
Cell Survival
Animals
Therapeutics
Optic Nerve Diseases
Neuroglia
Cell Death
Animal Models

Keywords

  • BDNF
  • Glaucoma
  • TrkB
  • neuroprotection
  • retinal ganglion cells

ASJC Scopus subject areas

  • Biomedical Engineering
  • Ophthalmology
  • Optometry

Cite this

Role of BDNF/TrkB pathway in the visual system : therapeutic implications for glaucoma. / Mysona, Barbara A.; Zhao, Jing; Bollinger, Kathryn E.

In: Expert Review of Ophthalmology, Vol. 12, No. 1, 02.01.2017, p. 69-81.

Research output: Contribution to journalReview article

@article{f85f0fd87dcb4f2a86c5864efcf014e9,
title = "Role of BDNF/TrkB pathway in the visual system: therapeutic implications for glaucoma",
abstract = "Introduction: Neuroprotective therapeutics are needed to treat glaucoma, an optic neuropathy that results in death of retinal ganglion cells (RGCs). Areas covered: The BDNF/TrkB pathway is important for RGC survival. Temporal and spatial alterations in the BDNF/TrkB pathway occur in development and in response to acute optic nerve injury and to glaucoma. In animal models, BDNF supplementation is successful at slowing RGC death after acute optic nerve injury and in glaucoma, however, the BDNF/TrkB signaling is not the only pathway supporting long term RGC survival. Expert commentary: Much remains to be discovered about the interaction between retrograde, anterograde, and retinal BDNF/TrkB signaling pathways in both neurons and glia. An ideal therapeutic agent for glaucoma likely has several modes of action that target multiple mechanisms of neurodegeneration including the BDNF/TrkB pathway.",
keywords = "BDNF, Glaucoma, TrkB, neuroprotection, retinal ganglion cells",
author = "Mysona, {Barbara A.} and Jing Zhao and Bollinger, {Kathryn E.}",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/17469899.2017.1259566",
language = "English (US)",
volume = "12",
pages = "69--81",
journal = "Expert Review of Ophthalmology",
issn = "1746-9899",
number = "1",

}

TY - JOUR

T1 - Role of BDNF/TrkB pathway in the visual system

T2 - therapeutic implications for glaucoma

AU - Mysona, Barbara A.

AU - Zhao, Jing

AU - Bollinger, Kathryn E.

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Introduction: Neuroprotective therapeutics are needed to treat glaucoma, an optic neuropathy that results in death of retinal ganglion cells (RGCs). Areas covered: The BDNF/TrkB pathway is important for RGC survival. Temporal and spatial alterations in the BDNF/TrkB pathway occur in development and in response to acute optic nerve injury and to glaucoma. In animal models, BDNF supplementation is successful at slowing RGC death after acute optic nerve injury and in glaucoma, however, the BDNF/TrkB signaling is not the only pathway supporting long term RGC survival. Expert commentary: Much remains to be discovered about the interaction between retrograde, anterograde, and retinal BDNF/TrkB signaling pathways in both neurons and glia. An ideal therapeutic agent for glaucoma likely has several modes of action that target multiple mechanisms of neurodegeneration including the BDNF/TrkB pathway.

AB - Introduction: Neuroprotective therapeutics are needed to treat glaucoma, an optic neuropathy that results in death of retinal ganglion cells (RGCs). Areas covered: The BDNF/TrkB pathway is important for RGC survival. Temporal and spatial alterations in the BDNF/TrkB pathway occur in development and in response to acute optic nerve injury and to glaucoma. In animal models, BDNF supplementation is successful at slowing RGC death after acute optic nerve injury and in glaucoma, however, the BDNF/TrkB signaling is not the only pathway supporting long term RGC survival. Expert commentary: Much remains to be discovered about the interaction between retrograde, anterograde, and retinal BDNF/TrkB signaling pathways in both neurons and glia. An ideal therapeutic agent for glaucoma likely has several modes of action that target multiple mechanisms of neurodegeneration including the BDNF/TrkB pathway.

KW - BDNF

KW - Glaucoma

KW - TrkB

KW - neuroprotection

KW - retinal ganglion cells

UR - http://www.scopus.com/inward/record.url?scp=85007247656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007247656&partnerID=8YFLogxK

U2 - 10.1080/17469899.2017.1259566

DO - 10.1080/17469899.2017.1259566

M3 - Review article

AN - SCOPUS:85007247656

VL - 12

SP - 69

EP - 81

JO - Expert Review of Ophthalmology

JF - Expert Review of Ophthalmology

SN - 1746-9899

IS - 1

ER -